Despite the above-mentioned discrepancy, it appears that GHRs are central to the regulation of the quinone redox state, likely preventing toxicity of quinones, either naturally present or found as environmental pollutants

1 In adults with obesity, along with diet and exercise, A well-studied safety profile for adults with obesity: Pooled safety data from 2 weight-management clinical trials evaluating Wegovy HD 7.2 mg 1 Wegovy HD (semaglutide) injection 7.2 mg had a safety profile consistent with Wegovy 2.4 mg 1,3 5% of patients with Wegovy HD 7.2 mg pen, 5% of patients with Wegovy 2.4 mg pen, and 2% of patients with placebo permanently discontinued as a result of adverse reactions 1 The most common adverse reactions leading to discontinuation were gastrointestinal disorders: 3% of patients with Wegovy HD 7.2 mg pen, 3% of patients with Wegovy 2.4 mg pen, and 0.3% of patients with placebo 1 Includes allodynia, burning sensation, dysesthesia, hyperesthesia, hyperpathia, pain of skin, paresthesia, sensitive skin, skin burning sensation, skin discomfort, and skin sensitization
On a side note: In the most severe case, the administration of a higher-dose Ozempic might cause heart attack, stroke, or death
Obese individuals with and without type 2 diabetes show different gut microbial functional capacity and composition
For instance, a head-to-head trial demonstrated that participants using Tirzepatide experienced an average weight loss of 20.2%, compared to 13.7% with Semaglutide
By contrast, peptides such as PYY and apelin were discontinued primarily due to formulation limitations or tolerability at supraphysiologic dosespharmacologic rather than biological failuresand therefore meet criteria for re-evaluation